A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2047-1440

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity ; volume:3 ; number:1 ; day:10 ; month:3 ; year:2014 ; pages:1-5 ; date:12.2014
Transplantation research ; 3, Heft 1 (10.3.2014), 1-5, 12.2014

Creator: Glick, Lauren
Shamy, Fernanda
Nash, Michelle
Sokwala, Ahmed
Malavade, Tushar
Prasad, GV Ramesh
Zaltzman, Jeffrey S.

Contributor: SpringerLink (Online service)

DOI: 10.1186/2047-1440-3-7

URN: urn:nbn:de:101:1-2019102816323498525860

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Glick, Lauren
Shamy, Fernanda
Nash, Michelle
Sokwala, Ahmed
Malavade, Tushar
Prasad, GV Ramesh
Zaltzman, Jeffrey S.
SpringerLink (Online service)

Other Objects (12)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization

Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Correction to: Once-Daily versus Twice Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies

Conversion of liver transplant recipients from twice-daily to novel once-daily Tacrolimus: a 2-year prospective study on adherence, safety, and efficacy

Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

Renal function and patient-reported outcomes in stable kidney transplant patients following conversion from twice-daily immediate-release tacrolimus to once-daily prolonged-release tacrolimus: a 12-month observational study in routine clinical practice in Germany (ADAGIO)

Related objects

Reset password